Evidence map›Paper›PMID 28822991›Full record

ArticleBiomolecules & therapeutics2017

Aquatide Activation of SIRT1 Reduces Cellular Senescence through a SIRT1-FOXO1-Autophagy Axis.

Chae Jin Lim, Yong-Moon Lee, Seung Goo Kang, Hyung W Lim, Kyong-Oh Shin, Se Kyoo Jeong, Yang Hoon Huh, Suin Choi, Myungho Kor, Ho Seong Seo and 5 more

Abstract read
In one paragraph

Article in Biomolecules & therapeutics, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Immunosenescence: signaling pathways, diseases and therapeutic targets.Signal transduction and targeted therapy · 2025
    Review
  6. Apoptotic Bodies Restore NAD and Mitochondrial Homeostasis in Fibroblasts.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Article
  7. Article
  8. PARP-2 mediates cardiomyocyte aging and damage induced by doxorubicin through SIRT1 Inhibition.Apoptosis : an international journal on programmed cell death · 2024
    Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Chae Jin LimDepartment of Microbiology and Molecular Biology, School of Bioscience and Biotechnology, Chungnam National University, Daejeon 34134, Republic of Korea.
Yong-Moon LeeCollege of Pharmacy Chungbuk National University, Cheongju 28644, Republic of Korea.
Seung Goo KangDivision of Biomedical Convergence and Institute of Bioscience & Biotechnology, Kangwon National University, Chuncheon 24341, Republic of Korea.
Hyung W LimGladstone Institute of Virology and Immunology, Gladstone Institute of Neurological Disease, School of Medicine, Department of Neurology, University of California, San Francisco, CA 94158, USA.
Kyong-Oh ShinCollege of Pharmacy Chungbuk National University, Cheongju 28644, Republic of Korea.
Se Kyoo JeongDepartment of Cosmetic Science, Seowon University, Cheongju 28674, Republic of Korea.
Yang Hoon HuhKorea Basic Science Institute, Cheongju 28119, Republic of Korea.
Suin ChoiKorea Basic Science Institute, Cheongju 28119, Republic of Korea.
Myungho KorPeptide R&D Center, Incospharm Corporation, Daejeon 34055, Republic of Korea.
Ho Seong SeoRadiation Biotechnology Research Division, Advanced Radiation Technology Institute, Korea Atomic Energy Research Institute, Jeongeup 26212, Republic of Korea.
Byeong Deog ParkNeoPharm USA, Englewood Cliffs, NJ 07632, USA.
Keedon ParkPeptide R&D Center, Incospharm Corporation, Daejeon 34055, Republic of Korea.
Jeong Keun AhnDepartment of Microbiology and Molecular Biology, School of Bioscience and Biotechnology, Chungnam National University, Daejeon 34134, Republic of Korea.
Yoshikazu UchidaDepartment of Dermatology, School of Medicine, University of California, San Francisco, and Northern California Institute for Research and Education, Veterans Affairs Medical Center, San Francisco, CA 94158, USA.
Kyungho ParkDepartment of Dermatology, School of Medicine, University of California, San Francisco, and Northern California Institute for Research and Education, Veterans Affairs Medical Center, San Francisco, CA 94158, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ultraviolet (UV) irradiation is a relevant environment factor to induce cellular senescence and photoaging. Both autophagy- and silent information regulator T1 (SIRT1)-dependent pathways are critical cellular processes of not only maintaining normal cellular functions, but also protecting cellular senescence in skin exposed to UV irradiation. In the present studies, we investigated whether modulation of autophagy induction using a novel synthetic SIRT1 activator, heptasodium hexacarboxymethyl dipeptide-12 (named as Aquatide), suppresses the UVB irradiation-induced skin aging. Treatment with Aquatide directly activates SIRT1 and stimulates autophagy induction in cultured human dermal fibroblasts. Next, we found that Aquatide-mediated activation of SIRT1 increases autophagy induction via deacetylation of forkhead box class O (FOXO) 1. Finally, UVB irradiation-induced cellular senescence measured by SA-β-gal staining was significantly decreased in cells treated with Aquatide in parallel to occurring SIRT1 activation-dependent autophagy. Together, Aquatide modulates autophagy through SIRT1 activation, contributing to suppression of skin aging caused by UV irradiation.

Indexed as

AquatideAutophagyCutaneous cellular senescenceSIRT1UV irradiation

Identifiers

PMID28822991
PMCPMC5590795

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.